Vertex Pharmaceuticals (VRTX) Change in Taxes (2011 - 2012)

Vertex Pharmaceuticals' (VRTX) quarterly Change in Taxes came in at -$3.2 million in Q4 2012, down 236.03% year-on-year from $2.3 million in Q1 2012, and down 185.99% quarter-over-quarter from $3.7 million in Q3 2012.

Vertex Pharmaceuticals (VRTX) Change in Taxes (2011 - 2012) Analysis & Trends

Vertex Pharmaceuticals' Change in Taxes history runs 2 years deep, the most recent figure standing at -$3.2 million for Q4 2012.

  • On a quarterly basis, Change in Taxes fell 236.03% year-over-year to -$3.2 million in Q4 2012; TTM through Dec 2012 was -$11.4 million, a N/A change from a year earlier, with the FY2012 full-year figure at -$11.4 million, down 194.08% from the prior year.
  • Change in Taxes retreated to -$3.2 million in Q4 2012 per VRTX's latest filing, from $3.7 million in the prior quarter.
  • Across five years, Change in Taxes topped out at $3.7 million in Q3 2012 and bottomed at -$11.9 million in Q1 2012.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -8,939.03
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2012 -3.16 Mn
Dec 31, 2012 -3.16 Mn
Sep 30, 2012 3.67 Mn
Sep 30, 2012 3.67 Mn
Mar 31, 2012 -11.87 Mn
Mar 31, 2012 -11.87 Mn
Dec 31, 2011 2.32 Mn
Dec 31, 2011 2.32 Mn
Sep 30, 2011 -5.46 Mn
Sep 30, 2011 -5.46 Mn